Alixia

Alixia is a platform therapeutics company that targets tumor heterogeneity. Our platform integrates developmental biology, biophysics and computational biology to identify molecules that disrupt the metabolic and inflammatory triggers within the tumor, enabling effective and durable cancer treatments.